Cite
HARVARD Citation
Beyerlin, K. et al. (2021). The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population. Journal of oncology pharmacy practice. pp. 1883-1890. [Online].